FDA Drug Application (091611) for ATAZANAVIR SULFATE by MATRIX LABS LTD

Back to FDA Applications sponsored by MATRIX LABS LTD

Application Number091611
Product Number001
FormCAPSULE; ORAL
Dosage150MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameATAZANAVIR SULFATE
Active IngredientATAZANAVIR SULFATE

Active IngredientCount
List of drugs with Active Ingredient ATAZANAVIR SULFATE6


Back to FDA Applications sponsored by MATRIX LABS LTD